Parthenolide is able to influence the level of EMT-related proteins and to treat pulmonary fibrosis by affecting the progression of pulmonary fibrosis through the NF-κB/Snail signaling pathway [15]. The gene discussed is SNAI1; the disease is pulmonary fibrosis.